Knocking out RPL15 using CRISPR technology significantly weakened lung metastasis in breast cancer circulating tumor cells in mouse models, and with RPL15 overexpression, breast cancer circulating tumor cells had stronger lung and ovarian metastasis ability [23]. Here, RPL15 is linked to breast carcinoma.